We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Pre- and Postoperative Use of GnRH Antagonists
Lee P. Shulman, MD, FACMG, FACOG
Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
Cut to the Chase: Why Not Treat Endometriosis With GnRH Antagonists First?
Sawsan As-Sanie, MD
James A. Simon, MD, CCD, NCMP, IF, FACOG
Innovations in the Management of Hemolytic Disease of the Fetus and Newborn: The Role of the Neonatal Fc Receptor (FcRn) Pathway
Kara B. Markham, MD
Kenneth J. Moise Jr., MD
Consensus Recommendations for Use of p16/Ki-67 Dual Staining Cytology in the Management of Individuals Testing Positive for HPV
Warner K. Huh, MD
Kimberly Levinson, MD, MPH
Mastering the AEs of ADCs to Unlock Their Full Potential in Breast, Lung, and Gynecologic Cancer
Nadia Harbeck, MD, PhD
Egbert Smit, MD
Susana Campos, MD, MPH
Managing Pulmonary and Cardiac Adverse Events Related to ADC Therapy in Breast Cancer
Hematologic Adverse Events With ADCs in Breast Cancer: Optimal Management Strategies
ADC-Related Hematologic Adverse Events
Optimal Management of ADC-Related Gastrointestinal AEs in NSCLC
ADCs on the Horizon for Breast Cancer: Managing Treatment-Emergent Toxicities
Gastrointestinal and Hematologic TEAEs Related to ADC Therapy in Gynecologic Cancers
Emerging ADC Therapies for NSCLC: Anticipating AEs Reported in Clinical Trials
Managing ADC-Related Pulmonary and Cardiac AEs in NSCLC
Risk Reduction and Management Protocols for Gastrointestinal Adverse Events With ADC Therapy in Breast Cancer
ADCs in Gynecologic Cancers: Managing Pulmonary and Cardiac TEAEs
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education